![Michael Bigham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bigham
Direttore/Membro del Consiglio presso
TeneoBio, Inc.
Profilo
Fondatore di Magellan Diagnostics, Inc., Michael F. Bigham è un uomo d'affari che è stato alla guida di 6 diverse aziende e attualmente è presidente esecutivo di Paratek Pharmaceuticals, Inc. È anche nel consiglio di Adamas Pharmaceuticals, Inc., Inmediata Health Group (ex presidente), inMediata Corp. e Frazier Lifesciences Acquisition Corp. In passato ha ricoperto la posizione di Chief Financial Officer & Executive VP-Operations presso Gilead Sciences, Inc., Executive Partner presso Abingworth Management Ltd. e Partner presso Abingworth LLP (una filiale di Abingworth Management Ltd.), Chairman & Chief Executive Officer di Paratek Pharmaceuticals, Inc, Presidente di Magellan Diagnostics, Inc., Direttore di Avila Therapeutics, Inc., Presidente e Amministratore delegato di Coulter Pharmaceuticals, Inc. e Partner & Co-Head-Healthcare Investment Banking di Hambrecht & Quist Group, Inc. Ha conseguito una laurea presso l'Università della Virginia e un MBA presso la Stanford University.
Posizioni attive di Michael Bigham
| Società | Posizione | Inizio |
|---|---|---|
TeneoBio, Inc.
 TeneoBio, Inc. Pharmaceuticals: MajorHealth Technology Develops human heavy chain antibodies for therapeutics against cancer | Direttore/Membro del Consiglio | - |
Nutcracker Therapeutics, Inc.
 Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Offers technology solutions for biotechnology industry | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Michael Bigham
| Società | Posizione | Fine |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Amministratore Delegato | 25/06/2019 |
| ADAMAS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 24/11/2021 |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Corporate Officer/Principal | 01/11/2015 |
| SUPERNUS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 23/12/2013 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Amministratore Delegato | 01/01/2012 |
Formazione di Michael Bigham
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
68
Relazioni di 1° grado
27
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 27 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Hambrecht & Quist Group, Inc.
 Hambrecht & Quist Group, Inc. Investment Banks/BrokersFinance Operates as a holding investment bank and provides securities brokerage services | Finance |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Xenogen Corp.
 Xenogen Corp. Medical SpecialtiesHealth Technology Provides real time in-vivo imaging services | Health Technology |
Dynogen Pharmaceuticals, Inc.
 Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Paratek Pharmaceuticals, Inc. /Old/
 Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative solutions for patients with infectious diseases | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
PrimeraDx, Inc.
 PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Health Technology |
Avedro, Inc.
 Avedro, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic pharmaceuticals & medical devices | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Abingworth Management Ltd.
 Abingworth Management Ltd. Investment ManagersFinance Operates as an investment firm | Finance |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
Magellan Diagnostics, Inc.
 Magellan Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic laboratory products | Health Technology |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases | Health Technology |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
Inmediata Health Group
 Inmediata Health Group Electronic Production EquipmentElectronic Technology Offers electronic solutions for enhancing the efficiency and the quality of health and dental care | Electronic Technology |
Paratek Pharmaceuticals, Inc.
 Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
inMediata Corp.
 inMediata Corp. Regional BanksFinance Provides payment reconciliation solutions | Finance |
TeneoBio, Inc.
TeneoBio, Inc. Pharmaceuticals: MajorHealth Technology Develops human heavy chain antibodies for therapeutics against cancer | Health Technology |
Magellan Biosciences, Inc.
 Magellan Biosciences, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for point-of-care systems, clinical laboratory instruments and analytical laboratory | Health Technology |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Offers technology solutions for biotechnology industry | Technology Services |
Frazier Lifesciences Acquisition Corp.
 Frazier Lifesciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
